Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.57 |
| ▸ | CASP1 | P29466 | 1/20 | 0.57 |
| ▸ | CASP7 | P55210 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30205812 | 1.00 | MAOA (0.57) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL143631 | 0.88 | MAOA (0.52) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL891550 | 0.83 | MAOA (0.68) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL8018963 | 0.81 | MAOA (0.46) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5385144 | 0.80 | KDM4E (0.52) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL23704523 | 0.79 | MAOA (0.44) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL8958450 | 0.79 | KDM4E (0.62) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL2256530 | 0.77 | CA12 (0.44) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL1217422 | 0.75 | MAOA (0.58) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL856949 | 0.73 | MAOA (0.38) | MAOAKDM4EALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11777147-B2 | Lithium ion secondary battery | NEC CORPORATION (JP) | 2023-10-03 | — | — | US | claimed |
| CN-111187148-B | Method for simultaneously preparing o-hydroxy phenetole and 1, 3-benzodioxole-2-one | 上海大学 | 2022-08-09 | — | — | CN | claimed |
| US-11142513-B2 | Method for simultaneously preparing 2-ethoxyphenol and 1,3-benzodioxolane-2-one | SHANGHAI UNIVERSITY | 2021-10-12 | — | — | US | claimed |
| CN-111187148-A | Method for simultaneously preparing o-hydroxy phenetole and 1, 3-benzodioxole-2-one | 上海大学 | 2020-05-22 | — | — | CN | claimed |
| WO-2013017216-A1 | ELECTROCHEMICAL CELL | LI-TEC BATTERY GMBH (DE) | 2013-02-07 | — | — | WO | claimed |
| WO-2012163485-A1 | ELECTROCHEMICAL CELL | LI-TEC BATTERY GMBH (DE) | 2012-12-06 | — | — | WO | claimed |
| US-8153307-B1 | Battery including electrolyte with mixed solvent | QUALLION LLC (US) | 2012-04-10 | — | — | US | claimed |
| US-7771496-B1 | Reduction of impurities in battery electrolyte | QUALLION LLC (US) | 2010-08-10 | — | — | US | claimed |
| WO-2004082686-A2 | USE OF COMPOUNDS WITH COMBINED 5-HT1A AND SSRI ACTIVITIES TO TREAT SEXUAL DYSFUNCTION | DYNOGEN PHARMACEUTICALS, INC. (US) | 2004-09-30 | — | — | WO | claimed |
| US-20040192730-A1 | Methods of using compounds with combined 5-HT1A and SSRI activities as-needed to treat sexual dysfunction | DYNOGEN PHARMACEUTICALS, INC. (US) | 2004-09-30 | — | — | US | claimed |
| WO-1998005652-A2 | ARTHROPODICIDAL AND FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-02-12 | — | — | WO | claimed |
| WO-1997000612-A1 | ARTHROPODICIDAL AND FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-01-09 | — | — | WO | claimed |
| WO-1996036616-A1 | FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-11-21 | — | — | WO | claimed |
| WO-1996036229-A1 | FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-11-21 | — | — | WO | claimed |
| WO-1996036633-A1 | FUNGICIDAL CYCLIC AMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1996-11-21 | — | — | WO | claimed |
| US-4536261-A | POLYMER CONTAINING HETEROCYCLIC NITROGEN RINGS | POPESCU FRANCINE (FR) | 1985-08-20 | — | — | US | claimed |
| US-4340690-A | Cyclic organo carbonate and sulfite coupling agents for living polymers of conjugated dienes | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1982-07-20 | — | — | US | claimed |
| US-4301258-A | OF BROADENED MOLECULAR WEIGHT DISTRIBUTION; HIGH IMPACT PLASTICS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1981-11-17 | — | — | US | claimed |
| US-4162947-A | AROMATIC SULFONIC ACID OR SALT, ZINC AND AMMONIUM COMPOUNDS | R. O. HULL & COMPANY, INC. (US) | 1979-07-31 | — | — | US | claimed |
| US-4146442-A | Zinc electroplating baths and process | R. O. HULL & COMPANY, INC. (US) | 1979-03-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192730-A1 | Methods of using compounds with combined 5-HT1A and SSRI activities as-needed to treat sexual dysfunction | HTR5A, HTR1A, HTR3A | MAOA 20/4885KDM4E 3958/4885ALDH1A1 529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.